Evidence map›Paper›PMID 21861274›Full record

ArticleAngewandte Chemie (International ed. in English)2011

Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen.

Sangeeta Ray Banerjee, Mrudula Pullambhatla, Youngjoo Byun, Sridhar Nimmagadda, Catherine A Foss, Gilbert Green, James J Fox, Shawn E Lupold, Ronnie C Mease, Martin G Pomper

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Preclinical Evaluation of a New Series of Albumin-BindingMolecules (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  11. Article
  12. Preclinical Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Preclinical Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sangeeta Ray BanerjeeThe Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, 1550 Orleans Street, 492 CRB II, Baltimore, MD 21231, USA.
Mrudula Pullambhatla
Youngjoo Byun
Sridhar Nimmagadda
Catherine A Foss
Gilbert Green
James J Fox
Shawn E Lupold
Ronnie C Mease
Martin G Pomper

Funding

PSMA-based Cancer Imaging AgentsR01CA134675 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI POMPER, MARTIN G · 2009 to 2025
$6.2M
Small Animal Imaging Resource (SAIR)U24CA092871 · NCI · JOHNS HOPKINS UNIVERSITY · PI POMPER, MARTIN G · 2007 to 2011
$2.3M
PSMA-based MR Imaging and Therapy of Prostate CancerK25CA148901 · NCI · JOHNS HOPKINS UNIVERSITY · PI RAY, SANGEETA · 2011 to 2015
$580k
NCI NIH HHS K25 CA148901NCI NIH HHS R01 CA134675NCI NIH HHS U24 CA092871NCI NIH HHS U24 CA92871
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsFluorescent DyesHeterocyclic Compounds, 1-RingIndium RadioisotopesMaleMicePeptidesPorphyrinsProstate-Specific AntigenProstatic NeoplasmsProtease InhibitorsTissue DistributionTomography, Emission-Computed, Single-PhotonTransplantation, Heterologous1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidFluorescent DyesHeterocyclic Compounds, 1-RingIndium RadioisotopesPeptidesPorphyrinsProstate-Specific AntigenProtease Inhibitors

Identifiers

PMID21861274
PMCPMC3192196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.